Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Vilma Valceckiene"'
Autor:
Regina Pileckyte, Vilma Valceckiene, Mindaugas Stoskus, Reda Matuzeviciene, Jurgita Sejoniene, Tadas Zvirblis, Laimonas Griskevicius
Publikováno v:
Medicina, Vol 55, Iss 11, p 719 (2019)
Background and Objectives: BTK and BCL2 inhibitors have changed the treatment paradigms of high-risk and elderly patients with chronic lymphocytic leukemia (CLL), but their long-term efficacy and toxicity are still unknown and the costs are considera
Externí odkaz:
https://doaj.org/article/44968006ae5f456f8592a8f0c7e74c46
Autor:
Mindaugas Stoškus, Jurgita Sejoniene, Tadas Zvirblis, Vilma Valceckiene, Reda Matuzeviciene, Laimonas Griskevicius, Regina Pileckyte
Publikováno v:
Medicina
Volume 55
Issue 11
Medicina; Volume 55; Issue 11; Pages: 719
Medicina, Basel : MDPI, 2019, vol. 55, no. 11, art. no. 719, p. [1-10]
Medicina, Kaunas; Basel : LSMU, MDPI, 2019, vol. 55, no. 11, art. no. 719, p. [1-10]
Medicina, Vol 55, Iss 11, p 719 (2019)
Volume 55
Issue 11
Medicina; Volume 55; Issue 11; Pages: 719
Medicina, Basel : MDPI, 2019, vol. 55, no. 11, art. no. 719, p. [1-10]
Medicina, Kaunas; Basel : LSMU, MDPI, 2019, vol. 55, no. 11, art. no. 719, p. [1-10]
Medicina, Vol 55, Iss 11, p 719 (2019)
Background and Objectives: BTK and BCL2 inhibitors have changed the treatment paradigms of high-risk and elderly patients with chronic lymphocytic leukemia (CLL), but their long-term efficacy and toxicity are still unknown and the costs are considera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bc3e3959a2f4e48f01a7a0c9783e613
Publikováno v:
British Journal of Haematology. 151:232-238
The clinical heterogeneity of B-cell chronic lymphocytic leukaemia (B-CLL) makes it necessary to identify potent prognostic indicators to predict individual clinical course and select risk-adapted therapy. In recent years, numerous gene expression mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5939b5f3e2922fd1abcbe3244bb20004
https://doi.org/10.1111/j.1365-2141.2010.08363.x
https://doi.org/10.1111/j.1365-2141.2010.08363.x
Autor:
Gintaras Kaubrys, Loreta Bagdonaite, Mindaugas Stoškus, Laimonas Griskevicius, Natasa Giedraitiene, Vilma Valceckiene, Rasa Kizlaitiene
Publikováno v:
Medical science monitor, Warsaw : Medical Science International, 2015, vol. 21, p. 1512-1519
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
Background: Neutralizing antibodies (NAb) to interferon-beta (IFN-b) are associated with reduced bioactivity and efficacy of IFN-b in multiple sclerosis (MS). The myxovirus resistance protein A (MxA) gene expression is one of the most appropriate mar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c099b8068ae22884c2e04be34a6c883f
https://repository.vu.lt/VU:ELABAPDB8811102&prefLang=en_US
https://repository.vu.lt/VU:ELABAPDB8811102&prefLang=en_US
Autor:
Mindaugas Stoškus, Jurgita Sejoniene, Laimonas Griskevicius, Vilma Valceckiene, Regina Pileckyte, Mindaugas Jurgutis, Egle Gineikiene, Tadas Zvirblis, Andrius Degulys
Publikováno v:
Leukemialymphoma. 52(6)
This study evaluated the efficacy and safety of dose-dense high-dose methylprednisolone (HDMP) plus rituximab (Rtx) in patients with high-risk CLL. Twenty-nine patients with relapsed or progressive CLL with adverse cytogenetics (17p deletion, TP53 mu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a1921b7ae822e75d5678845b1e77cf1
https://pubmed.ncbi.nlm.nih.gov/21599591
https://pubmed.ncbi.nlm.nih.gov/21599591
Autor:
Regina Pileckyte, Mindaugas Stoškus, Vilma Valceckiene, Beatrice Valatkaite, Egle Gineikiene, Laimonas Griskevicius
Publikováno v:
Blood cells, moleculesdiseases. 46(4)
Insulin-like growth factor 2 mRNA-binding proteins IGF2BP1, IGF2BP2, and IGF2BP3 have been shown to have diagnostic and prognostic utility in a number of epithelial and soft tissue tumors. Still, little is known about the expression of these molecule
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4346c9b7bf2d4bfd6b6b5c242d8d8148
https://pubmed.ncbi.nlm.nih.gov/21414819
https://pubmed.ncbi.nlm.nih.gov/21414819
Publikováno v:
British journal of haematology. 151(3)
The clinical heterogeneity of B-cell chronic lymphocytic leukaemia (B-CLL) makes it necessary to identify potent prognostic indicators to predict individual clinical course and select risk-adapted therapy. In recent years, numerous gene expression mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b7c91c92cc5668621f9a35eac453a63f
https://pubmed.ncbi.nlm.nih.gov/20813001
https://pubmed.ncbi.nlm.nih.gov/20813001
Autor:
Kristina Andrekute, A. Jakubauskas, Arvydas Kanopka, Laimonas Griskevicius, Vilma Valceckiene, Dmitrij Seinin
Publikováno v:
Experimental and molecular pathology. 90(2)
The most common recurrent translocation in clear cell sarcoma t(12;22)(q13;q12) results in an EWSR1/ATF1 chimeric gene. We present a molecular analysis of tumor overgrowing right proximal tibia with bone destruction metastatic to two groin lymph node
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9beada410be432fb6a8c95efd19aafb6
https://pubmed.ncbi.nlm.nih.gov/21510931
https://pubmed.ncbi.nlm.nih.gov/21510931